89bio Inc Stock Investor Sentiment

ETNB Stock  USD 8.96  0.20  2.28%   
About 54% of 89bio's investors are presently thinking to get in. The analysis of the overall investor sentiment regarding 89bio Inc suggests that some traders are interested. The current market sentiment, together with 89bio's historical and current headlines, can help investors time the market. In addition, many technical investors use 89bio Inc stock news signals to limit their universe of possible portfolio assets.
  
over six months ago at news.google.com         
89bio Trading Up 3.3 percent - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
89bio Trading Up 3.3 percent - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
89bio Stock Price Down 7.5 percent - MarketBeat
Google News at Macroaxis
over six months ago at finance.yahoo.com         
89bio Initiates Phase 3 ENLIGHTEN-Fibrosis Trial of Pegozafermin in Non-Cirrhotic Metabolic Dysfunct...
Yahoo News
over six months ago at thelincolnianonline.com         
Oppenheimer Reaffirms Market Perform Rating for 89bio
news
over six months ago at thelincolnianonline.com         
89bio Stock Rating Reaffirmed by Cantor Fitzgerald
news
over six months ago at finance.yahoo.com         
89bio Announces Inducement Grant Under Nasdaq Listing Rule 5635
Yahoo News
over six months ago at benzinga.com         
89bio Announces Inducement Grant Under Nasdaq Listing Rule 5635
benzinga news
over six months ago at news.google.com         
Insider Trading Director Boosts Stake in 89bio Stock - TipRanks.com - TipRanks
Google News at Macroaxis
over six months ago at zacks.com         
Novo Nordisk Down Despite Kidney Outcomes Study Success
zacks News
over six months ago at finance.yahoo.com         
89BIO Just Overtook the 200-Day Moving Average
Yahoo News
over six months ago at globenewswire.com         
89bio to Participate in the Leerink Partners Global Biopharma Conference
Macroaxis News: globenewswire.com
over six months ago at zacks.com         
89BIO Just Overtook the 200-Day Moving Average
zacks News
over six months ago at zacks.com         
Wall Street Analysts Believe 89BIO Could Rally 121.5 percent Heres is How to Trade
zacks News
over six months ago at news.google.com         
Acquisition by Ra Capital Management, L.p. of 1350000 shares of 89bio at 15.35 subject to Rule 16b-3
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about 89bio that are available to investors today. That information is available publicly through 89bio media outlets and privately through word of mouth or via 89bio internal channels. However, regardless of the origin, that massive amount of 89bio data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of 89bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of 89bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to 89bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive 89bio alpha.

89bio Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for 89bio Stock analysis

When running 89bio's price analysis, check to measure 89bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 89bio is operating at the current time. Most of 89bio's value examination focuses on studying past and present price action to predict the probability of 89bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 89bio's price. Additionally, you may evaluate how the addition of 89bio to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device